Ameriflex Group Inc. Grows Stake in UnitedHealth Group Incorporated $UNH

Ameriflex Group Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,938 shares of the healthcare conglomerate’s stock after buying an additional 92 shares during the quarter. Ameriflex Group Inc.’s holdings in UnitedHealth Group were worth $587,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of UNH. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock valued at $4,257,131,000 after purchasing an additional 196,696 shares during the period. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its stake in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after buying an additional 847,054 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $360.17 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a PEG ratio of 2.30 and a beta of 0.47. The business has a fifty day moving average of $307.84 and a 200 day moving average of $355.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the firm earned $6.80 EPS. The business’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Morgan Stanley lifted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.